[HTML][HTML] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD …
MT Dransfield, G Feldman, P Korenblat, CF LaForce… - Respiratory …, 2014 - Elsevier
Background Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta 2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta 2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
[PDF][PDF] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
M Dransfield, G Feldman, P Korenblat… - RESPIRATORY …, 2014 - flore.unifi.it
Background: Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
[HTML][HTML] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD …
MT Dransfield, G Feldman, P Korenblat… - Respiratory …, 2014 - resmedjournal.com
Background Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta 2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta 2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
[PDF][PDF] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
MT Dransfield, G Feldman, P Korenblat… - Respiratory …, 2014 - researchgate.net
Background: Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
MT Dransfield, G Feldman, P Korenblat, CF LaForce… - Respiratory …, 2014 - infona.pl
Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting beta 2-agonist
(ICS/LABA), recently approved as once-daily maintenance therapy for COPD. We compared …
(ICS/LABA), recently approved as once-daily maintenance therapy for COPD. We compared …
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
MT Dransfield, G Feldman, P Korenblat… - Respiratory …, 2014 - hero.epa.gov
Background Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
[PDF][PDF] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
MT Dransfield, G Feldman, P Korenblat… - Respiratory …, 2014 - academia.edu
Background: Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
MT Dransfield, G Feldman, P Korenblat, CF LaForce… - 2014 - pubmed.ncbi.nlm.nih.gov
Background Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
[PDF][PDF] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
MT Dransfield, G Feldman, P Korenblat… - Respiratory …, 2014 - scholar.archive.org
Background: Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
[PDF][PDF] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
MT Dransfield, G Feldman, P Korenblat… - Respiratory …, 2014 - cyberleninka.org
Background: Fluticasone furoate/vilanterol (FF/VI) is an inhaled corticosteroid/long-acting
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …
beta2-agonist (ICS/LABA), recently approved as once-daily maintenance therapy for COPD …